Opinion|Videos|June 12, 2024
Clinical Decision-Making for Alzheimer Disease Management
Experts provide their perspectives on clinical factors taken into consideration when deciding on a treatment plan for a patient with Alzheimer disease.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- When deciding on a treatment plan for a patient with AD, what clinical factors do you take into consideration? (eg, results of testing, time since diagnosis, severity of symptoms, impact on patient/family/caregivers, efficacy, mechanism of action, monitoring requirements)
Advertisement
Related to this article
Adults with moderately to severely active Crohn disease can now start risankizumab with an on-body injector at home and keep using the same device for maintenance. They no longer need intravenous infusions to begin.
For all the advances in breast cancer, there remains unmet need for patients whose cancer progresses after treatment with antibody-drug conjugates (ADCs). In the final week of Breast Cancer Awareness Month, AJMC® looks at an investigational vaccine approach that could come after ADCs, offering patients a low-toxicity regimen.
Hiddo Heerspink, PhD, discusses finerenone data in type 1 diabetes, FSGS and IgA nephropathy, and open questions on sequencing CKD therapies.
Advertisement
Advertisement
Trending on AJMC
1
IDWeek Studies Tie RSV, Flu, and COVID-19 to Harm After Acute Illness
2
Preparing for Hepatitis B Functional Cure: Jordan Feld, MD, MPH
3
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
4
Colonization vs Infection: Rethinking C. Diff Prevention
5